| Literature DB >> 31602919 |
Xiao-Yue Wang1, Tai-Xian Li1, Zhi-Peng Xue2, Cheng Lyu3, Hui-Zhen Li3, Yuan-Fang Fan1, Yi-Qun Li1, Ya-Ge Tian1, Jun Yang1, Wen-Jia Chen1, Min-Qun Guo1, Jing-Xia Wang1, Hong-Yan Wu1, Yan-Qiong Zhang1, Na Lin1.
Abstract
To systematically review the improvement effects of Tripterygium Glycosides Tables( TGT) alone or in combination with methotrexate( MTX) on the clinical signs and symptoms of rheumatoid arthritis( RA),and provide a basis for the rational use of TGT in clinic,in the current study,six literature databases including CNKI,Wan Fang,VIP,PubMed,EMbase,and Cochrane Library,were systematically searched,according to the inclusion and exclusion criteria. Review Manager 5.3 software was used to input the literatures,and we assessed the risk bias on the level of outcome indicators for each included literature. A total of 18 literatures were included,and the classification results showed that: compared with MTX,TGT alone can reduce the number of joint swelling( MD =0. 18,95%CI[-1.06,1.42],P = 0.78) and joint tenderness( MD =-0.06,95% CI[-1.69,1.56],P = 0.94) in RA patients with the same effect as MTX. In terms of drug combination,TGT combined with MTX had an advantage over MTX alone in lessening the morning stiffness time( MD = 18. 24,95% CI[12. 64,23. 84],P < 0. 000 01) of RA,joint tenderness( MD = 2. 65,95% CI[1. 85,3. 44],P<0.000 01) and joint swelling( MD = 3.01,95% CI[2.09,3.39],P< 0.000 01). In conclusion,this Meta-analysis suggest that TGT alone was superior to MTX in improving joint swelling and tenderness in RA patients,TGT combined with MTX may improve the clinical manifestation of RA patients better than MTX alone.Entities:
Keywords: Meta-analysis; Tripterygium Glycosides Tablets; clinical symptoms; methotrexate; rheumatoid arthritis
Mesh:
Substances:
Year: 2019 PMID: 31602919 DOI: 10.19540/j.cnki.cjcmm.20190605.501
Source DB: PubMed Journal: Zhongguo Zhong Yao Za Zhi ISSN: 1001-5302